Cargando…
SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer
BACKGROUND: Fluorouracil (FU)-based chemotherapy regimens are indispensable in the comprehensive treatment of colorectal cancer (CRC). However, the heterogeneity of treated individuals and the severe adverse effects of chemotherapy results in limited overall benefit. METHODS: Firstly, Weighted gene...
Autores principales: | Weng, Siyuan, Liu, Zaoqu, Ren, Xiaofeng, Xu, Hui, Ge, Xiaoyong, Ren, Yuqing, Zhang, Yuyuan, Dang, Qin, Liu, Long, Guo, Chunguang, Beatson, Richard, Deng, Jinhai, Han, Xinwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283651/ https://www.ncbi.nlm.nih.gov/pubmed/35844556 http://dx.doi.org/10.3389/fimmu.2022.873871 |
Ejemplares similares
-
Integrative pharmacogenomics revealed three subtypes with different immune landscapes and specific therapeutic responses in lung adenocarcinoma
por: Ge, Xiaoyong, et al.
Publicado: (2022) -
ALOX12: A Novel Insight in Bevacizumab Response, Immunotherapy Effect, and Prognosis of Colorectal Cancer
por: Weng, Siyuan, et al.
Publicado: (2022) -
Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2023) -
Artificial intelligence‐driven consensus gene signatures for improving bladder cancer clinical outcomes identified by multi‐center integration analysis
por: Xu, Hui, et al.
Publicado: (2022) -
A New Trend in Cancer Treatment: The Combination of Epigenetics and Immunotherapy
por: Liu, Zaoqu, et al.
Publicado: (2022)